These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29215471)

  • 1. Long-term outcomes of a recanalized thrombus treated with a paclitaxel-coated balloon: insights from optical coherence tomography.
    Watanabe Y; Fujino Y; Ishiguro H; Nakamura S
    Coron Artery Dis; 2018 Sep; 29(6):530-532. PubMed ID: 29215471
    [No Abstract]   [Full Text] [Related]  

  • 2. Recanalized Thrombus Treated With a Paclitaxel-Coated Balloon: Insights from Optical Coherence Tomography.
    Watanabe Y; Fujino Y; Ishiguro H; Nakamura S
    JACC Cardiovasc Interv; 2016 Mar; 9(6):618-20. PubMed ID: 27013163
    [No Abstract]   [Full Text] [Related]  

  • 3. Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography.
    Poerner TC; Duderstadt C; Goebel B; Kretzschmar D; Figulla HR; Otto S
    Clin Res Cardiol; 2017 Jan; 106(1):18-27. PubMed ID: 27379610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late Structural Discontinuity as a Possible Cause of Very Late Everolimus-Eluting Bioresorbable Scaffold Thrombosis.
    Ielasi A; Cortese B; Steffenino G
    JACC Cardiovasc Interv; 2015 Aug; 8(10):e171-e172. PubMed ID: 26315753
    [No Abstract]   [Full Text] [Related]  

  • 5. First in human: imaging guided bioresorbable magnesium scaffolds in acute myocardial infarction.
    Alfonso F; García-Guimaraes M; Bastante T; González-Bartol E; Cuesta J; Rivero F
    Coron Artery Dis; 2018 Aug; 29(5):441-443. PubMed ID: 29537986
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: Results from the multi-center randomized controlled PATENT-C first in human trial.
    Scheller B; Fontaine T; Mangner N; Hoffmann S; Bonaventura K; Clever YP; Chamie D; Costa R; Gershony G; Kelsch B; Kutschera M; Généreux P; Cremers B; Böhm M; Speck U; Abizaid A
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):51-9. PubMed ID: 26331782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first.
    Gutiérrez-Chico JL; van Geuns RJ; Koch KT; Koolen JJ; Duckers H; Regar E; Serruys PW
    EuroIntervention; 2011 Oct; 7(6):711-22. PubMed ID: 21986329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel paclitaxel-coated scoring ballon for de novo complex coronary lesions-first report.
    di Palma G; Cortese B
    Cardiovasc Revasc Med; 2018; 19(3 Pt B):390-392. PubMed ID: 28923693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the effect of paclitaxel-eluting stents and paclitaxel-eluting balloon in the treatment of in-stent restenosis.
    Cheng J; Gao C; Liu Y; Wang Z; Zheng X; Qi D
    Pak J Pharm Sci; 2017 Jul; 30(4(Suppl.)):1521-1524. PubMed ID: 29044008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Year Follow-Up of the Balloon Elution and Late Loss Optimization Study (BELLO).
    Latib A; Ruparelia N; Menozzi A; Castriota F; Micari A; Cremonesi A; De Felice F; Marchese A; Tespili M; Presbitero P; Sgueglia GA; Buffoli F; Tamburino C; Varbella F; Colombo A
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1132-1134. PubMed ID: 26205451
    [No Abstract]   [Full Text] [Related]  

  • 12. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
    Wöhrle J; Werner GS
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
    Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractional flow reserve-guided paclitaxel-coated balloon treatment for de novo coronary lesions.
    Shin ES; Ann SH; Balbir Singh G; Lim KH; Kleber FX; Koo BK
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):193-200. PubMed ID: 26423017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collapse of a Bioresorbable Novolimus-Eluting Coronary Scaffold.
    Braun D; Baquet M; Massberg S; Mehilli J; Hausleiter J
    JACC Cardiovasc Interv; 2016 Jan; 9(1):e13-e14. PubMed ID: 26685077
    [No Abstract]   [Full Text] [Related]  

  • 16. First-in-Human Study of Paclitaxel Drug-Coated Chocolate Coronary Percutaneous Transluminal Coronary Angioplasty Balloon Catheter in De Novo Coronary Artery Lesions.
    Garcia-Lithgow C; Tirziu D; Zhou S; Bouras G; Shah T; Grubman D; Javier JJ; Mustapha JA; Abizaid A; Lansky AJ
    JACC Cardiovasc Interv; 2019 Dec; 12(24):2568-2570. PubMed ID: 31857033
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis.
    Nijhoff F; Stella PR; Troost MS; Belkacemi A; Nathoe HM; Voskuil M; Samim M; Doevendans PA; Agostoni P
    Clin Res Cardiol; 2016 May; 105(5):401-11. PubMed ID: 26541146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous coronary intervention for treating de-novo lesions in small coronary vessels: initial experience with the Essential paclitaxel-coated balloon.
    Abellas-Sequeiros RA; Benezet J; Agarrado Luna A; Oneto Otero J; Déry JP; Cieza T; DeLarochellière R; Duocastella L; Gomez A; Molina M; Asmarats L; Pelletier-Beaumont E; Puri R; Rodés-Cabau J
    Coron Artery Dis; 2018 Sep; 29(6):477-481. PubMed ID: 29621009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels.
    Giannini F; Latib A; Ancona MB; Costopoulos C; Ruparelia N; Menozzi A; Castriota F; Micari A; Cremonesi A; De Felice F; Marchese A; Tespili M; Presbitero P; Sgueglia GA; Buffoli F; Tamburino C; Varbella F; Colombo A
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):380-386. PubMed ID: 28109036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
    Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
    EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.